Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDITION 1: Toujeo vs Lantus in T2DM with Mealtime Insulin
NCT01499082Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2011
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 3 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2011; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01499082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499082.